SU
Sudarshan Pharma Industries Ltd (SUDARSHAN)
₹29.01
Mkt cap
₹753 Cr
P/E ratio
25.90
P/B
3.78
Div yield
0.00%
ROE
16.30%
ROCE
15.10%
EPS (TTM)
₹1.12
Book value
₹8
52W range
29–39
Sector
Commodities
Price history
Previous close
Incorporated in 2008, Sudarshan Pharma Industries Ltd manufactures API and Pharmaceutical Items. It also trades in Chemicals and Solvents [1]
NSE SUDARSHANBSE 543828
Health check
Constructive
ValuationFair
ProfitabilityStrong
GrowthHigh
TechnicalsNeutral
52-week range
−26.18% from high₹29
₹29+1.75% from low₹39
Current
₹29.01
Prev close
₹30.94
Day
−6.24%
Price performance
1D
−6.24%
1W
−11.31%
1M
—
3M
—
6M
—
1Y
—
YTD
−16.30%
Financials
Revenue, profit & margin
P/E ratio
25.9×
SUDARSHAN is 3% above the sector median of 25.1×
SUDARSHAN25.9×
Sector median25.1×
| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 99.20 | 128.58 | 115.66 | 161.59 | 145.26 | 168.87 | 168.01 | 220.92 | 174.42 | 216.97 | |
| YoY Sales growth | +46.43% | +31.33% | +45.26% | +36.72% | +20.07% | +28.48% | |||||
| Expenses | 97.12 | 115.53 | 107.69 | 145.66 | 134.22 | 159.66 | 157.14 | 200.72 | 158.52 | 196.38 | |
| Operating Profit | 2.08 | 13.05 | 7.97 | 15.93 | 11.04 | 9.21 | 10.87 | 20.20 | 15.90 | 20.59 | |
| OPM % | 2.10% | 10.15% | 6.89% | 9.86% | 7.60% | 5.45% | 6.47% | 9.14% | 9.12% | 9.49% | |
| Other Income | 0.98 | -0.85 | 0.51 | -0.81 | 1.21 | 1.86 | 1.52 | 4.13 | 1.22 | 1.93 | |
| Interest | 3.94 | 3.70 | 4.00 | 4.40 | 5.96 | 5.94 | 6.28 | 7.53 | 8.21 | 10.36 | |
| Depreciation | 0.67 | 0.67 | 0.63 | 0.83 | 0.88 | 0.90 | 0.91 | 1.09 | 1.41 | 1.36 | |
| Profit before tax | -1.55 | 7.83 | 3.85 | 9.89 | 5.41 | 4.23 | 5.20 | 15.71 | 7.50 | 10.80 | |
| Tax % | -21.94% | 24.90% | 24.94% | 25.08% | 26.80% | 8.51% | 20.19% | 27.43% | 25.33% | 27.96% | |
| Net Profit | -1.21 | 5.88 | 2.88 | 7.41 | 3.96 | 3.87 | 4.15 | 11.40 | 5.61 | 7.78 | |
| EPS in Rs | -0.05 | 0.24 | 0.12 | 0.31 | 0.17 | 0.17 | 0.18 | 0.45 | 0.23 | 0.32 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
No reaction history yet.
No quarterly filings ingested yet.
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Sep 202657.81%Promoter
Promoters57.81%1.12
FIIs21.94%2.56
Public20.19%1.46
Government0.05%
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Pidilite Inds. | ₹1,620.00 | 61.62 | 1,65,370 | 0.71% | 626 | +6.09% | 4,298 | +20.91% | 31.02% |
| Gujarat Fluoroch | ₹4,932.70 | 79.38 | 54,113 | 0.06% | 240 | +35.75% | 1,760 | +45.45% | 9.64% |
| Navin Fluo.Intl. | ₹10,077.00 | 56.49 | 51,750 | 0.15% | 269 | +81.46% | 1,191 | +57.00% | 20.96% |
| Aether Industri. | ₹1,620.30 | 85.35 | 21,510 | 0.00% | 68 | +21.62% | 347 | +23.96% | 11.92% |
| Deepak Nitrite | ₹1,531.20 | 19.47 | 20,860 | 0.49% | 398 | +234.99% | 3,076 | +61.75% | 11.37% |
| Fine Organic | ₹5,488.50 | 34.94 | 16,828 | 0.20% | 152 | +40.14% | 729 | +22.12% | 21.47% |
| Aarti Industries | ₹449.50 | 26.87 | 16,289 | 0.22% | 168 | +100.00% | 3,669 | +74.71% | 6.86% |
| Sudarshan Pharma | ₹29.90 | 25.93 | 753 | 0.00% | 8 | +93.54% | 217 | +28.48% | 15.13% |
| Median: 95 Co. | ₹318.00 | 25.12 | 846 | 0.28% | 11 | +36.39% | 172 | +28.92% | 14.16% |
Filings
Concall transcripts11
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer 9 Nov - Nirav Shah resigned as Company Secretary and Compliance Officer effective 9 November 2026.Announcement under Regulation 30 (LODR)-Investor Presentation 7 Nov - As per Regulation 30 read with Para A of Part A of Schedule III to the SEBI (LODR) Regulations, 2015, we hereby submit the updated …Announcement under Regulation 30 (LODR)-Newspaper Publication 6 Nov - The newspaper advertisement for the Unaudited Standalone and Consolidated Financial Results for the quarter and half yearly ended 30/Sept/2026, published in ....Announcement under Regulation 30 (LODR)-Issue of Securities 30 Oct - Board approved issue of convertible warrants up to Rs 72 crore to promoters, subject to EGM approval.Announcement under Regulation 30 (LODR)-Issue of Securities 30 Oct - Board approved issue of up to 72 crore warrants to promoters, subject to approvals and EGM.






